Table of Contents
1. Methodology and Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Definitions forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
2 Market Overview
2.1 Dermatological Disorders Medications Introduction
2.2 Market Analysis by Type
2.2.1 Prescription Drugs
2.2.2 Over-The-Counter Drugs
2.3 Market Analysis by Applications
2.3.1 Hospital Pharmacies
2.3.2 Online Pharmacies
2.3.3 Retail Pharmacies
2.4 Market Analysis by Regions
2.4.1 North America (United States, Canada and Mexico)
2.4.1.1 United States Market States and Outlook (2013-2026)
2.4.1.2 Canada Market States and Outlook (2013-2026)
2.4.1.3 Mexico Market States and Outlook (2013-2026)
2.4.2 Europe (Germany, France, UK, Russia and Italy)
2.4.2.1 Germany Market States and Outlook (2013-2026)
2.4.2.2 France Market States and Outlook (2013-2026)
2.4.2.3 UK Market States and Outlook (2013-2026)
2.4.2.4 Russia Market States and Outlook (2013-2026)
2.4.2.5 Italy Market States and Outlook (2013-2026)
2.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
2.4.3.1 China Market States and Outlook (2013-2026)
2.4.3.2 Japan Market States and Outlook (2013-2026)
2.4.3.3 Korea Market States and Outlook (2013-2026)
2.4.3.4 India Market States and Outlook (2013-2026)
2.4.3.5 Southeast Asia Market States and Outlook (2013-2026)
2.4.4 South America, Middle East and Africa
2.4.4.1 Brazil Market States and Outlook (2013-2026)
2.4.4.2 Egypt Market States and Outlook (2013-2026)
2.4.4.3 Saudi Arabia Market States and Outlook (2013-2026)
2.4.4.4 South Africa Market States and Outlook (2013-2026)
2.4.4.5 Nigeria Market States and Outlook (2013-2026)
2.5 Market Dynamics
2.5.1 Market Opportunities
2.5.2 Market Risk
2.5.3 Market Driving Force
2.6 Market Competition News and Trend
2.6.1 Merger, Consolidation or Acquisition News
2.6.2 Investment or Disinvestment News
2.6.3 New Product Development and Launch
3 Global Dermatological Disorders Medications Market Competition, by Manufacturer
3.1 Global Dermatological Disorders Medications Sales and Market Share by Manufacturer (2016-2018)
3.2 Global Dermatological Disorders Medications Revenue and Market Share by Manufacturer (2016-2018)
3.3 Global Dermatological Disorders Medications Price by Manufacturer (2016-2018)
3.4 Market Concentration Rate
3.4.1 Top 3 Dermatological Disorders Medications Manufacturer Market Share in 2018
3.4.2 Top 5 Dermatological Disorders Medications Manufacturer Market Share in 2018
3.5 Market Competition Trend
4 Manufacturers Profiles
4.1 Mylan Pharmaceuticals
4.1.1 Business Overview
4.1.1.1 Mylan Pharmaceuticals Description
4.1.1.2 Mylan Pharmaceuticals Headquarter, Main Business and Finance Overview
4.1.2 Mylan Pharmaceuticals Product Name Product Introduction
4.1.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.1.2.2 Mylan Pharmaceuticals Product Name Product Introduction
4.1.3 Mylan Pharmaceuticals Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.1.3.1 Mylan Pharmaceuticals Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.1.3.2 Global Mylan Pharmaceuticals Product Name Market Share in 2018
4.2 Pfizer
4.2.1 Business Overview
4.2.1.1 Pfizer Description
4.2.1.2 Pfizer Headquarter, Main Business and Finance Overview
4.2.2 Pfizer Product Name Product Introduction
4.2.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.2.2.2 Pfizer Product Name Product Introduction
4.2.3 Pfizer Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.2.3.1 Pfizer Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.2.3.2 Global Pfizer Product Name Market Share in 2018
4.3 Roche
4.3.1 Business Overview
4.3.1.1 Roche Description
4.3.1.2 Roche Headquarter, Main Business and Finance Overview
4.3.2 Roche Product Name Product Introduction
4.3.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.3.2.2 Roche Product Name Product Introduction
4.3.3 Roche Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.3.3.1 Roche Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.3.3.2 Global Roche Product Name Market Share in 2018
4.4 Almirall
4.4.1 Business Overview
4.4.1.1 Almirall Description
4.4.1.2 Almirall Headquarter, Main Business and Finance Overview
4.4.2 Almirall Product Name Product Introduction
4.4.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.4.2.2 Almirall Product Name Product Introduction
4.4.3 Almirall Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.4.3.1 Almirall Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.4.3.2 Global Almirall Product Name Market Share in 2018
4.5 Bausch Health
4.5.1 Business Overview
4.5.1.1 Bausch Health Description
4.5.1.2 Bausch Health Headquarter, Main Business and Finance Overview
4.5.2 Bausch Health Product Name Product Introduction
4.5.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.5.2.2 Bausch Health Product Name Product Introduction
4.5.3 Bausch Health Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.5.3.1 Bausch Health Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.5.3.2 Global Bausch Health Product Name Market Share in 2018
4.6 Barrier Therapeutics
4.6.1 Business Overview
4.6.1.1 Barrier Therapeutics Description
4.6.1.2 Barrier Therapeutics Headquarter, Main Business and Finance Overview
4.6.2 Barrier Therapeutics Product Name Product Introduction
4.6.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.6.2.2 Barrier Therapeutics Product Name Product Introduction
4.6.3 Barrier Therapeutics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.6.3.1 Barrier Therapeutics Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.6.3.2 Global Barrier Therapeutics Product Name Market Share in 2018
4.7 PharmaDerm
4.7.1 Business Overview
4.7.1.1 PharmaDerm Description
4.7.1.2 PharmaDerm Headquarter, Main Business and Finance Overview
4.7.2 PharmaDerm Product Name Product Introduction
4.7.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.7.2.2 PharmaDerm Product Name Product Introduction
4.7.3 PharmaDerm Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.7.3.1 PharmaDerm Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.7.3.2 Global PharmaDerm Product Name Market Share in 2018
4.8 Bristol-Myers Squibb
4.8.1 Business Overview
4.8.1.1 Bristol-Myers Squibb Description
4.8.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
4.8.2 Bristol-Myers Squibb Product Name Product Introduction
4.8.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.8.2.2 Bristol-Myers Squibb Product Name Product Introduction
4.8.3 Bristol-Myers Squibb Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.8.3.1 Bristol-Myers Squibb Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.8.3.2 Global Bristol-Myers Squibb Product Name Market Share in 2018
4.9 Galderma
4.9.1 Business Overview
4.9.1.1 Galderma Description
4.9.1.2 Galderma Headquarter, Main Business and Finance Overview
4.9.2 Galderma Product Name Product Introduction
4.9.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.9.2.2 Galderma Product Name Product Introduction
4.9.3 Galderma Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.9.3.1 Galderma Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.9.3.2 Global Galderma Product Name Market Share in 2018
4.10 GlaxoSmithKline
4.10.1 Business Overview
4.10.1.1 GlaxoSmithKline Description
4.10.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
4.10.2 GlaxoSmithKline Product Name Product Introduction
4.10.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.10.2.2 GlaxoSmithKline Product Name Product Introduction
4.10.3 GlaxoSmithKline Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.10.3.1 GlaxoSmithKline Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.10.3.2 Global GlaxoSmithKline Product Name Market Share in 2018
4.11 Novartis
4.11.1 Business Overview
4.11.1.1 Novartis Description
4.11.1.2 Novartis Headquarter, Main Business and Finance Overview
4.11.2 Novartis Product Name Product Introduction
4.11.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.11.2.2 Novartis Product Name Product Introduction
4.11.3 Novartis Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.11.3.1 Novartis Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.11.3.2 Global Novartis Product Name Market Share in 2018
4.12 Sinclair Pharma
4.12.1 Business Overview
4.12.1.1 Sinclair Pharma Description
4.12.1.2 Sinclair Pharma Headquarter, Main Business and Finance Overview
4.12.2 Sinclair Pharma Product Name Product Introduction
4.12.2.1 Dermatological Disorders Medications Production Bases, Sales Regions and Major Competitors
4.12.2.2 Sinclair Pharma Product Name Product Introduction
4.12.3 Sinclair Pharma Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.12.3.1 Sinclair Pharma Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.12.3.2 Global Sinclair Pharma Product Name Market Share in 2018
5 Global Dermatological Disorders Medications Market Analysis by Regions
5.1 Global Dermatological Disorders Medications Sales, Revenue and Market Share by Regions
5.1.1 Global Dermatological Disorders Medications Sales by Regions (2013-2018)
5.1.2 Global Dermatological Disorders Medications Revenue by Regions (2013-2018)
5.2 North America Dermatological Disorders Medications Sales, Revenue and Growth Rate (2013-2018)
5.3 Europe Dermatological Disorders Medications Sales, Revenue and Growth Rate (2013-2018)
5.4 Asia-Pacific Dermatological Disorders Medications Sales, Revenue and Growth Rate (2013-2018)
5.5 South America Dermatological Disorders Medications Sales, Revenue and Growth Rate (2013-2018)
5.6 Middle East and Africa Dermatological Disorders Medications Sales, Revenue and Growth Rate (2013-2018)
6 North America Dermatological Disorders Medications by Countries, Type, Application and Manufacturers
6.1 North America Dermatological Disorders Medications Sales, Revenue and Market Share by Countries
6.1.1 North America Dermatological Disorders Medications Sales by Countries (2013-2018)
6.1.2 North America Dermatological Disorders Medications Revenue by Countries (2013-2018)
6.1.3 United States Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
6.1.4 Canada Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
6.1.5 Mexico Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
6.2 North America Dermatological Disorders Medications Sales and Revenue (Value) by Manufacturers (2016-2018)
6.2.1 North America Dermatological Disorders Medications Sales by Manufacturers (2016-2018)
6.2.2 North America Dermatological Disorders Medications Revenue by Manufacturers (2016-2018)
6.3 North America Dermatological Disorders Medications Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 North America Dermatological Disorders Medications Sales and Sales Share by Type (2013-2018)
6.3.2 North America Dermatological Disorders Medications Revenue and Revenue Share by Type (2013-2018)
6.4 North America Dermatological Disorders Medications Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 North America Dermatological Disorders Medications Sales and Sales Share by Application (2013-2018)
6.4.2 North America Dermatological Disorders Medications Revenue and Revenue Share by Application (2013-2018)
7 Europe Dermatological Disorders Medications by Countries, Type, Application and Manufacturers
7.1 Europe Dermatological Disorders Medications Sales, Revenue and Market Share by Countries
7.1.1 Europe Dermatological Disorders Medications Sales by Countries (2013-2018)
7.1.2 Europe Dermatological Disorders Medications Revenue by Countries (2013-2018)
7.1.3 Germany Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
7.1.4 UK Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
7.1.5 France Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
7.1.6 Russia Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
7.1.7 Italy Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
7.2 Europe Dermatological Disorders Medications Sales and Revenue (Value) by Manufacturers (2016-2018)
7.2.1 Europe Dermatological Disorders Medications Sales by Manufacturers (2016-2018)
7.2.2 Europe Dermatological Disorders Medications Revenue by Manufacturers (2016-2018)
7.3 Europe Dermatological Disorders Medications Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Europe Dermatological Disorders Medications Sales and Sales Share by Type (2013-2018)
7.3.2 Europe Dermatological Disorders Medications Revenue and Revenue Share by Type (2013-2018)
7.4 Europe Dermatological Disorders Medications Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Europe Dermatological Disorders Medications Sales and Sales Share by Application (2013-2018)
7.4.2 Europe Dermatological Disorders Medications Revenue and Revenue Share by Application (2013-2018)
8 Asia-Pacific Dermatological Disorders Medications by Countries, Type, Application and Manufacturers
8.1 Asia-Pacific Dermatological Disorders Medications Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Dermatological Disorders Medications Sales by Countries (2013-2018)
8.1.2 Asia-Pacific Dermatological Disorders Medications Revenue by Countries (2013-2018)
8.1.3 China Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
8.1.4 Japan Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
8.1.5 Korea Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
8.1.6 India Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
8.1.7 Southeast Asia Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
8.2 Asia-Pacific Dermatological Disorders Medications Sales and Revenue (Value) by Manufacturers (2016-2018)
8.2.1 Asia-Pacific Dermatological Disorders Medications Sales by Manufacturers (2016-2018)
8.2.2 Asia-Pacific Dermatological Disorders Medications Revenue by Manufacturers (2016-2018)
8.3 Asia-Pacific Dermatological Disorders Medications Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 Asia-Pacific Dermatological Disorders Medications Sales and Sales Share by Type (2013-2018)
8.3.2 Asia-Pacific Dermatological Disorders Medications Revenue and Revenue Share by Type (2013-2018)
8.4 Asia-Pacific Dermatological Disorders Medications Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 Asia-Pacific Dermatological Disorders Medications Sales and Sales Share by Application (2013-2018)
8.4.2 Asia-Pacific Dermatological Disorders Medications Revenue and Revenue Share by Application (2013-2018)
9 South America Dermatological Disorders Medications by Countries, Type, Application and Manufacturers
9.1 South America Dermatological Disorders Medications Sales, Revenue and Market Share by Countries
9.1.1 South America Dermatological Disorders Medications Sales by Countries (2013-2018)
9.1.2 South America Dermatological Disorders Medications Revenue by Countries (2013-2018)
9.1.3 Brazil Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
9.1.4 Argentina Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
9.1.5 Colombia Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
9.2 South America Dermatological Disorders Medications Sales and Revenue (Value) by Manufacturers (2016-2018)
9.2.1 South America Dermatological Disorders Medications Sales by Manufacturers (2016-2018)
9.2.2 South America Dermatological Disorders Medications Revenue by Manufacturers (2016-2018)
9.3 South America Dermatological Disorders Medications Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 South America Dermatological Disorders Medications Sales and Sales Share by Type (2013-2018)
9.3.2 South America Dermatological Disorders Medications Revenue and Revenue Share by Type (2013-2018)
9.4 South America Dermatological Disorders Medications Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 South America Dermatological Disorders Medications Sales and Sales Share by Application (2013-2018)
9.4.2 South America Dermatological Disorders Medications Revenue and Revenue Share by Application (2013-2018)
10 Middle East and Africa Dermatological Disorders Medications by Countries, Type, Application and Manufacturers
10.1 Middle East and Africa Dermatological Disorders Medications Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Dermatological Disorders Medications Sales by Countries (2013-2018)
10.1.2 Middle East and Africa Dermatological Disorders Medications Revenue by Countries (2013-2018)
10.1.3 Saudi Arabia Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
10.1.4 UAE Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
10.1.5 Egypt Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
10.1.6 Nigeria Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
10.1.7 South Africa Dermatological Disorders Medications Sales and Growth Rate (2013-2018)
10.2 Middle East and Africa Dermatological Disorders Medications Sales and Revenue (Value) by Manufacturers (2016-2018)
10.2.1 Middle East and Africa Dermatological Disorders Medications Sales by Manufacturers (2016-2018)
10.2.2 Middle East and Africa Dermatological Disorders Medications Revenue by Manufacturers (2016-2018)
10.3 Middle East and Africa Dermatological Disorders Medications Sales, Revenue and Market Share by Type (2013-2018)
10.3.1 Middle East and Africa Dermatological Disorders Medications Sales and Sales Share by Type (2013-2018)
10.3.1 Middle East and Africa Dermatological Disorders Medications Revenue and Revenue Share by Type (2013-2018)
10.4 Middle East and Africa Dermatological Disorders Medications Sales, Revenue and Market Share by Application (2013-2018)
10.4.1 Middle East and Africa Dermatological Disorders Medications Sales and Sales Share by Application (2013-2018)
10.4.2 Middle East and Africa Dermatological Disorders Medications Revenue and Revenue Share by Application (2013-2018)
11 Global Dermatological Disorders Medications Market Segment by Type
11.1 Global Dermatological Disorders Medications Sales, Revenue and Market Share by Type (2013-2018)
11.1.1 Global Dermatological Disorders Medications Sales and Market Share by Type (2013-2018)
11.1.2 Global Dermatological Disorders Medications Revenue and Market Share by Type (2013-2018)
11.2 Prescription Drugs Sales Growth Rate and Price
11.2.1 Global Prescription Drugs Sales Growth Rate (2013-2018)
11.2.2 Global Prescription Drugs Price (2013-2018)
11.3 Over-The-Counter Drugs Sales Growth Rate and Price
11.3.1 Global Over-The-Counter Drugs Sales Growth Rate (2013-2018)
11.3.2 Global Over-The-Counter Drugs Price (2013-2018)
12 Global Dermatological Disorders Medications Market Segment by Application
12.1 Global Dermatological Disorders Medications Sales Market Share by Application (2013-2018)
12.2 Hospital Pharmacies Sales Growth Rate (2013-2018)
12.3 Online Pharmacies Sales Growth Rate (2013-2018)
12.4 Retail Pharmacies Sales Growth Rate (2013-2018)
13 Dermatological Disorders Medications Market Forecast (2019-2026)
13.1 Global Dermatological Disorders Medications Sales, Revenue and Growth Rate (2019-2026)
13.2 Dermatological Disorders Medications Market Forecast by Regions (2019-2026)
13.2.1 North America Dermatological Disorders Medications Market Forecast (2019-2026)
13.2.2 Europe Dermatological Disorders Medications Market Forecast (2019-2026)
13.2.3 Asia-Pacific Dermatological Disorders Medications Market Forecast (2019-2026)
13.2.4 South America Dermatological Disorders Medications Market Forecast (2019-2026)
13.2.5 Middle East and Africa Dermatological Disorders Medications Market Forecast (2019-2026)
13.3 Dermatological Disorders Medications Market Forecast by Type (2019-2026)
13.3.1 Global Dermatological Disorders Medications Sales Forecast by Type (2019-2026)
13.3.2 Global Dermatological Disorders Medications Market Share Forecast by Type (2019-2026)
13.4 Dermatological Disorders Medications Market Forecast by Application (2019-2026)
13.4.1 Global Dermatological Disorders Medications Sales Forecast by Application (2019-2026)
13.4.2 Global Dermatological Disorders Medications Market Share Forecast by Application (2019-2026)
14 Sales Channel, Distributors, Traders and Dealers
14.1 Sales Channel
14.1.1 Direct Marketing
14.1.2 Indirect Marketing
14.1.3 Marketing Channel Future Trend
14.2 Market Positioning
14.2.1 Pricing Strategy
14.2.2 Brand Strategy
14.2.3 Target Client
14.3 Distributors, Traders and Dealers
15 Research Findings and Conclusion